当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析

梅花生物

(600873)

  

流通市值:316.88亿  总市值:316.88亿
流通股本:28.04亿   总股本:28.04亿

梅花生物(600873)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润30.25亿元,每股收益1.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1611583.48万元,未分配利润1219574.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2599133.99万元,负债987550.51万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入18,215,447,34512,280,450,603.536,268,563,075.4625,069,288,294.62
营业总成本15,834,727,996.4210,368,912,543.025,214,885,039.0521,862,599,657.62
其他经营收益
营业利润2,658,930,345.812,096,399,627.921,206,030,880.483,491,284,796.47
利润总额3,442,504,529.332,089,170,850.251,202,262,709.833,349,460,691.13
净利润3,025,092,355.051,767,950,116.891,018,706,366.462,740,427,215.56
每股收益
其他综合收益-80,102,163.16-98,666,362.69-78,900,353.95-60,692,608.96
综合收益总额2,944,990,191.891,669,283,754.2939,806,012.512,679,734,606.6
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计9,862,310,001.348,841,594,093.269,499,388,391.598,899,880,069.39
非流动资产:
非流动资产合计16,129,029,901.7615,159,903,439.8714,797,470,081.9814,909,677,942.27
资产总计25,991,339,903.124,001,497,533.1324,296,858,473.5723,809,558,011.66
流动负债:
流动负债合计7,646,482,274.566,847,181,423.826,991,289,327.797,438,989,489.18
非流动负债:
非流动负债合计2,229,022,859.092,174,181,395.091,854,106,796.611,795,623,221.55
负债合计9,875,505,133.659,021,362,818.918,845,396,124.49,234,612,710.73
所有者权益(或股东权益):
归属于母公司股东权益合计16,115,834,769.4514,980,134,714.2215,451,462,349.1714,574,945,300.93
股东权益合计16,115,834,769.4514,980,134,714.2215,451,462,349.1714,574,945,300.93
负债和股东权益合计25,991,339,903.124,001,497,533.1324,296,858,473.5723,809,558,011.66
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计20,713,725,008.5713,450,929,765.846,754,619,422.6828,306,256,369.45
经营活动现金流出小计16,002,565,010.2311,138,138,545.216,301,352,351.9923,679,541,578.98
经营活动产生的现金流量净额4,711,159,998.342,312,791,220.63453,267,070.694,626,714,790.47
投资活动产生的现金流量:
投资活动现金流入小计69,029,336.3591,637,275.9431,726,103.26245,600,886.59
投资活动现金流出小计3,643,711,406.983,034,934,871.822,182,847,932.672,894,559,694.3
投资活动产生的现金流量净额-3,574,682,070.63-2,943,297,595.88-2,151,121,829.41-2,648,958,807.71
筹资活动产生的现金流量:
筹资活动现金流入小计4,743,961,248.873,303,480,417.491,624,172,167.726,686,830,180.6
筹资活动现金流出小计5,785,108,571.334,113,628,860.221,447,935,110.159,424,882,464.29
筹资活动产生的现金流量净额-1,041,147,322.46-810,148,442.73176,237,057.57-2,738,052,283.69
汇率变动对现金及现金等价物的影响25,528,099.831,539,177.2322,189,675.61111,541,460.34
现金及现金等价物净增加额120,858,705.05-1,409,115,640.75-1,499,428,025.54-648,754,840.59
期末现金及现金等价物余额4,252,718,307.192,722,743,961.392,632,431,576.724,131,859,602.14
补充资料:
现金及现金等价物的净增加额--1,409,115,640.75--648,754,840.59
最新报告期:2025-11-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国海证券李永磊,杨丽蓉,董伯骏1.251.221.332025-11-01
中金公司侯一林,裘孝锋,贾雄伟1.201.14--2025-10-30
华泰证券张雄,庄汀洲,杨泽鹏1.261.271.362025-10-30
长江证券马太1.111.191.232025-10-29
中信建投卢昊,邓天泽1.081.281.402025-10-27
TOP↑